呼吸及其他-碳青霉烯治疗多重耐药非发酵细菌感染的策略详解.ppt

呼吸及其他-碳青霉烯治疗多重耐药非发酵细菌感染的策略详解.ppt

  1. 1、本文档共63页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
* * * This slide illustrates comparisons of hospital costs and length of stay in patients with resistant and sensitive Gram-negative rod (GNR) infections A retrospective analysis reanalyzed a previously defined cohort of 924 consecutive GNR infections occurring between December 1996 and September 2000 in a university hospital surgical ICU and ward [Evans/p89/col3] The analysis included 604 surgical patients with GNR infections [Evans/p90/col2] 467 sensitive and 137 resistant infections [Evans/p90/col2] Resistance was defined as resistance to all drugs in 1 or more of the following antibiotic classes: aminoglycosides, cephalosporins, carbapenems, and fluoroquinolones [Evans/p89/col3-p90/col1] Emergence of resistance was defined as subsequent detection of resistance to at least 1 class of antibiotics after previous isolation of the same GNR species without resistance [Evans/p90/col1] As compared with patients having sensitive GNR infections, patients with resistant GNR infections had: [Evans/p91/Table2] Higher median hospital costs ($80,500 vs $29,604; P0.0001) Higher median antibiotic costs ($2,607 vs $758; P0.0001) Longer median hospital length of stay (29 days vs 13 days; P0.0001) Longer median ICU length of stay (13 days vs 1 day; P0.0001) Reference 1. Evans HL, Lefrak SN, Lyman J, et al. Cost of gram-negative resistance. Crit Care Med. 2007;35:89-95. * Ref 1, Lawrence 2009, p 435, Fig 1 Antimicrobial stewardship is a multifaceted approach to improving antimicrobial use. The goals of antimicrobial stewardship include combating the emergence of bacterial resistance, improving clinical outcomes, and controlling costs. Ref 1, Lawrence, p 434, C1, ?1, 1-5 Reference Lawrence KL, Kollef MH. Antimicrobial stewardship in the intensive care unit. Advances and obstacles. Am J Respir Crit Care Med. 2009;179:434-438. * * A 3-year, prospective, controlled, quasi-experimental study was conducted in 3 ICUs for a 1-year period before a multifaceted infection control

文档评论(0)

三哥 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档